Maternal obesity during pregnancy and gestational diabetes mellitus (GDM) are both
associated with of several postnatal diseases in the offspring, including obesity, early onset …

Background Women at risk of gestational diabetes mellitus (GDM) need preventative
interventions. Objective To evaluate targeted interventions before and during pregnancy for …

Abstract Background Polycystic Ovary Syndrome (PCOS) is an endocrine disorder that
affects women in reproductive age and represents an unfavourable risk factor for several …

Background Lifestyle choices, metformin, and dietary supplements may prevent GDM, but
the effect of intervention characteristics has not been identified. This review evaluated …

Previous randomized and observational studies on the efficacy of metformin in pregnancy to
reduce incident gestational diabetes mellitus (GDM) in women at high risk (obesity …

The incidence of obesity is rising rapidly worldwide with the consequence that more women
are entering pregnancy overweight or obese. This leads to an increased incidence of clinical …

Background Maternal obesity increases the risk for pregnancy complications and adverse
neonatal outcome and has been associated with long-lasting adverse effects in the …

Background Metformin for women with overweight or obesity during pregnancy has been
evaluated in randomized trials to reduce adverse pregnancy and birth outcomes. The effect …

Polycystic ovary syndrome (PCOS) is characterized by the presence of insulin resistance,
and women with PCOS have high prevalence of gestational diabetes (GDM). Both …

Our hypothesis is that myoinositol and metformin in pregnant women with high-risk factors
for glucose intolerance would reduce insulin resistance and consequently lower the …